The structural profiles are close, with EssilorLuxottica Société anonyme carrying a narrow edge on growth. Jazz Pharmaceuticals still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, Jazz Pharmaceuticals carries the stronger setup — intact trend against EssilorLuxottica Société anonyme's broken trend. That leaves a split case: the structural lead stays with EssilorLuxottica Société anonyme, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (EL.PA: STOXX 600, JAZZ: Russell 1000).
On growth, the clearer edge sits with Jazz Pharmaceuticals plc, while the overall score remains tighter and points the other way.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
Most of the shared profile comes through revenue stability and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
The price setup looks more supportive for Jazz Pharmaceuticals plc, but EssilorLuxottica Société anonyme still has the stronger structure.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where EL.PA and JAZZ each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The main growth separation is wide, driven by a meaningfully stronger expansion profile.
Profitability still favours Jazz Pharmaceuticals, with a 13.3-point operating margin advantage keeping the comparison from looking fully resolved.
Growth points one way, even though the overall score still points the other way.
Break down the EL.PA vs JAZZ comparison across all dimensions with the full interactive tool.
Explore how EL.PA and JAZZ each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.